Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.41 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.41 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.41 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27914015 | 0.98 | SPHK1 (0.47) | SPHK1CHRNB2CHRNB4CHRNA4GPR84 | |
| SCHEMBL9950172 | 0.93 | CHRNB2 (0.42) | SPHK1CHRNB2CHRNB4CHRNA4 | |
| SCHEMBL5949014 | 0.85 | OPRM1 (0.48) | SPHK1OPRM1CA1LMNATP53 | |
| SCHEMBL11861454 | 0.83 | OPRM1 (0.46) | SPHK1OPRM1LMNA | |
| SCHEMBL9949853 | 0.83 | TSHR (0.36) | CHRNB2CHRNB4CHRNA4LMNA | |
| SCHEMBL5948800 | 0.83 | OPRM1 (0.46) | SPHK1OPRM1LMNA | |
| SCHEMBL29281611 | 0.83 | TP53 (0.42) | SPHK1CHRNB2CHRNB4CHRNA4GPR84 | |
| SCHEMBL21126444 | 0.81 | OPRM1 (0.44) | SPHK1OPRM1CA1LMNATP53 | |
| SCHEMBL1687785 | 0.80 | OPRM1 (0.48) | SPHK1OPRM1CHRNB2CHRNB4CHRNA4 | |
| SCHEMBL9626907 | 0.80 | SPHK1 (0.47) | SPHK1OPRM1GPR84FFAR1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106943848-B | Carbon dioxide capture system and method of operating a carbon dioxide capture system | 株式会社东芝 | 2021-04-13 | — | — | CN | disclosed |
| EP-2705894-B1 | Acid gas absorbent, acid gas removal method and acid gas removal device | TOSHIBA KK (JP) | 2018-05-23 | — | — | EP | disclosed |
| EP-2468385-B1 | Acid gas absorbent, acid gas removal method and acid gas removal device | TOSHIBA KK (JP) | 2016-11-02 | — | — | EP | disclosed |
| US-9409119-B2 | Acid gas absorbent, acid gas removal method, and acid gas removal device | KABUSHIKI KAISHA TOSHIBA (JP) | 2016-08-09 | — | — | US | disclosed |
| EP-2705894-A1 | Acid gas absorbent, acid gas removal method and acid gas removal device | Kabushiki Kaisha Toshiba (JP) | 2014-03-12 | — | — | EP | disclosed |
| CN-102553395-A | Acid gas absorbent, acid gas removal method and acid gas removal device | TOSHIBA KK | 2012-07-11 | — | — | CN | disclosed |
| US-20120161071-A1 | ACID GAS ABSORBENT, ACID GAS REMOVAL METHOD, AND ACID GAS REMOVAL DEVICE | KABUSHIKI KAISHA TOSHIBA (JP) | 2012-06-28 | — | — | US | disclosed |
| EP-2468385-A2 | Acid gas absorbent, acid gas removal method and acid gas removal device | Kabushiki Kaisha Toshiba (JP) | 2012-06-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120161071-A1 | ACID GAS ABSORBENT, ACID GAS REMOVAL METHOD, AND ACID GAS REMOVAL DEVICE | ALKBH1, ALKBH3, ALKBH2 | SPHK1 3316/4885OPRM1 824/4885CHRNB2 3445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.